# Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

> **NCT02357992** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 122 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **RADIATION:** Stereotactic Body Radiotherapy (SABR)

## Key facts

- **NCT ID:** NCT02357992
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04-05
- **Primary completion:** 2021-09-17
- **Final completion:** 2021-09-17
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2022-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02357992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02357992, "Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02357992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*